EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Artificial Cells: Perspective on Reconstructing Biological Cells and “Out of the Box” Innovations

Thomas Ming Swi Chang iD

ChemBioChem · 26.06.2026 · 27 (12)

DOI: 10.1002/cbic.202500933 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ChemBioChem, online erschienen am 17.06.2026. Verfasst von Thomas Ming Swi Chang. Beteiligte Einrichtung: Artificial Cells and Organs Research Centre, Departments of Physiology, Medicine and Biomedical Engineering, Faculty of Medicine & Biomedical Science…. Hauptthemen laut MEDLINE: Artificial Cells, Erythrocytes. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Virage Centre of Excellence in High Technology award, McGill University Advancement Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The first artificial cell (Chang 1957, 1964) was in the form of artificial red blood cells (RBCs), one of the most important cells because all cells, tissues, organs, and indeed the human being need it for survival. I first reconstructed artificial RBCs in vitro. This is made of cellular dimensions with ultrathin membranes of polymer, crosslinked protein, protein–lipid, or lipid. The next step in this work is to develop this for actual use to replace RBCs in the body. This is a more complex task requiring modifying the configuration and dimensions. Instead of starting with all three functions, a bottom‐up approach is used. First, one with only oxygen transport function shows promising results in clinical trials with patients. A future direction is the development of artificial cells that have all three red blood cell functions including antioxidant, oxygen, and CO 2 transport. My research group has also been doing innovative research going outside the box of RBCs. This way, extensive variations in contents, membranes, dimensions, and configurations are possible. This allows for worldwide and innovative applications that encompass hemoperfusion, delivery systems, COVID‐19 vaccines, cancer therapy, therapy for hereditary enzyme defects like phenylketonuria, cell/stem cell therapy, microbes, nanomedicine, biotherapeutics, gene therapy, regenerative medicine, agricultural applications, aquatic culture, fermentation, nanorobotics, and other areas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial CellsErythrocytesHumansOxygen

Stichwörter der Autor:innen

ArtificialBiotechnologyCellsNanomedicineSynthetic

Substanzen

Oxygen

Autor:innen und Institutionen

  • Artificial Cells and Organs Research Centre, Departments of Physiology, Medicine and Biomedical Engineering, Faculty of Medicine & Biomedical Sciences, McGill University, Montreal, Quebec, Canada.

ORCID-Profile: Thomas Ming Swi Chang

Förderung

  • Virage Centre of Excellence in High Technology award, McGill University Advancement Program

Zitieren

APA

Chang, T. M. S. (2026). Artificial Cells: Perspective on Reconstructing Biological Cells and “Out of the Box” Innovations. ChemBioChem, 27(12). https://doi.org/10.1002/cbic.202500933

Vancouver

Chang TMS. Artificial Cells: Perspective on Reconstructing Biological Cells and “Out of the Box” Innovations. ChemBioChem. 2026;27(12). doi:10.1002/cbic.202500933

BibTeX
@article{Chang2026,
  author = {Chang, Thomas Ming Swi},
  title = {Artificial Cells: Perspective on Reconstructing Biological Cells and “Out of the Box” Innovations},
  journal = {ChemBioChem},
  year = {2026},
  volume = {27},
  number = {12},
  doi = {10.1002/cbic.202500933}
}
Kostenlos starten →